The Medicines (MDCO)
36.90
+0.21 +0.57%
NASDAQ
Jun 15, 20:00
Delayed 2m
USD
View All Key Stats
MDCO Key Stats
| Income Statement | |
| Revenue (TTM) | 28.34M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -7.95 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -576.55M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 64.78% |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 2.716B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 95.08 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 40.15 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -109.33M |
| Return on Equity (TTM) | Upgrade |
View All MDCO News
MDCO News
-
WireHeadlineTime (ET)
-
SA Breaking News06/07 08:09
-
MT Newswires06/07 07:47
-
Yahoo05/29 08:30
-
Yahoo05/25 09:11
-
Yahoo05/24 07:15
-
MT Newswires05/21 16:32
-
MT Newswires05/07 12:44
-
Business Wire05/07 10:45
-
Yahoo05/03 07:50
-
Business Wire04/30 07:00
View All Events
MDCO Events
| Date | Type | Description |
|---|---|---|
| 08/09/2018 | Misc | The Medicines Co Second Quarter Earnings Conference Call in 2018 |
| 08/09/2018 | Earnings | The Medicines Co Second Quarter Earnings Results in 2018 |
| 05/31/2018 | Misc | The Medicines Co Annual General Meeting in 2017 |
| 04/25/2018 08:30 EDT | Misc | The Medicines Co First Quarter Earnings Conference Call in 2018 |
| 04/25/2018 | Earnings | The Medicines Co First Quarter Earnings Results in 2018 |
| 03/01/2018 | Misc | The Medicines Co Annual Report in 2017 |
| 02/21/2018 08:30 EST | Misc | The Medicines Co Fourth Quarter Earnings Conference Call in 2017 |
| 02/21/2018 | Earnings | The Medicines Co Fourth Quarter Earnings Results in 2017 |
| 01/23/2018 10:00 EDT | Misc | The Medicines Company Investor Day |
| 12/13/2017 | Misc | The Medicines Company to Host Investor Day on January 23, 2018 |
MDCO Fundamentals
Income Statement View Statement
MDCO Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MDCO One Page Reports
- One Page Report Download
MDCO Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 36.90 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.themedicinescompany.com
- Investor Relations URL: http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-irhome
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Blend
- Next Earnings Release: Aug. 09, 2018
- Last Earnings Release: Apr. 25, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: The Medicines Co is a pharmaceutical company. It provides transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The company’s products are Angiomax, Ionsys, Minocin for injection and Orbactiv.
MDCO Excel Add-In Codes
- Name: =YCI("MDCO","name")
- Description: =YCI("MDCO","description")
- Sector: =YCI("MDCO","sector")
- Industry: =YCI("MDCO","industry")
- Est. Current Fiscal Year End: =YCI("MDCO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MDCO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MDCO Tweets Stocktwits
Advertisement
